JPRN-jRCT1080220081未知Unknown
A randomized phase III trial of S-1 versus S-1 plus irinotecan in advanced gastric cancer.
Yakult Honsha Co., Ltd. ,DAIICHI SANKYO Co.,Ltd.0 个研究点开始时间: 2005年9月9日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 75age old（—）
- 性别
- All
入选标准
- •Histologically confirmed unresectable or relapsed gastric cancer
- •Neither prior chemotherapy nor prior radiotherapy
- •Age between 20 and 75 years old
- •ECOG Performance Status: 0-2
排除标准
- 未提供
研究者
相似试验
已完成
3 期
A phase III trial of S-1 vs. observation in patients with resected biliary tract cancer ASCOT : Adjuvant S-1 for CholangiOcarcinoma Trial (JCOG1202, ASCOT)JPRN-UMIN000011688Japan Clinical Oncology Group (JCOG)350
已完成
3 期
Randomized phase III trial comparing adjuvant S-1 to capecitabine in stage III colorectal cancer (JCOG0910, CRC Adj-CAPS)Stage III colorectal cancerJPRN-UMIN000003272Japan Clinical Oncology Group(JCOG)1,550
已完成
3 期
A randomized controlled study comparing S-1 with UFT as postoperative adjuvant Chemotherapy in Rectal Cancer.Rectal CancerJPRN-C000000385Japanese Foundation for Multidisciplinary Treatment of Cancer800
招募中
不适用
Phase III study of S-1 plus intravenous and introperitoneal paclitaxel for pancreatic ductal adenocarcinoma patients with peritoneal metastasispancreatic ductal adenocarcinoma patients with peritoneal metastasisJPRN-UMIN000027229Study group of pancreatic cancer with peritoneal metastasis180
进行中（未招募）
不适用
A Phase 3, randomized, double-blind study of the safety and efficacy of GSK1349572 plus abacavir/lamivudine fixed-dose combination therapy administered once daily compared to Atripla over 96 weeks in HIV-1 infected antiretroviral therapy na?ve adult subjects. - SINGLEHIV-1 infected antiretroviral therapy naive adult subjectsMedDRA version: 9.1Level: LLTClassification code 10008922EUCTR2010-020983-39-ITViiV Healthcare UK Limited800